Phase 4 N=12 Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study
Bacterial Vaginosis
Primary: Number of Participants With Bacterial Vaginosis Recurrence — 8 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=200 Prevalence of Femoroacetabular Impingement in Asymptomatic Patients
Femoroacetabular Hip Impingement Syndrome
Primary: Prevalence of Femoroacetabular Impingement (FAI) — 28; 172 Participants
N/A N=81 Clinical Characterization of Symptomatic Populations
Ametropia
Primary: Meibomian Gland Imaging — 10; 4; 23; 66 eyes
N/A N=900 Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64
Coronary Artery Disease
Primary: Number of Participants With Combination of All Cause Death, Non-fatal Myocardial Infarction (MI), and Hospitalization for Unstable Angina — 34; 28 Participants
N/A N=170 Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates
Cognitive Manifestations
Primary: Composite Cognitive Score — 45.5; 47.9 units on a scale
N/A N=110 Restricted Reporting for Positive Urine Cultures
Bacteriuria · Urinary Tract Infection
Primary: The Number of Patients Receiving Appropriate Treatment — 44; 29 Participants
N/A N=100 Modified Reporting of Positive Urine Cultures Collected From Long Term Care
Urinary Tract Infections · Asymptomatic Bacteriuria
Primary: Proportion of Asymptomatic Bacteriuria Treated With Antibiotics and Urinary Tract Infection Treated With Antibiotics — 31; 25 Participants
N/A N=193 Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome
Diabetes · Metabolic Syndrome
Primary: Systolic BP Pressure — 145; 144 mm Hg
N/A N=200 Urinalysis Results in Healthy Individuals
Asymptomatic Bacteriuria · Asymptomatic Pyuria
Primary: False Positive Urine — 6; 40 Participants
N/A N=20 Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions
High Grade Anal Canal Squamous Intraepithelial Neoplasia · Human Immunodeficiency Virus
Primary: Development of Spanish-language Version of the Anal Cancer/High-grade Squamous Intraepithelial Lesions (HSIL) Outcomes Research (ANCHOR) Health-related Quality of Life…
Phase 3 N=1,088 Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer
Prostate Cancer
Primary: Overall Survival — 34.66; 30.29 Months
N/A N=214 Symptom-Based Markers for COVID-19 Transmission
Covid19
Primary: Body Temperature — 98.1 degrees Fahrenheit
N/A N=215 Incidence of HANA Conditions in HIV-infected Individuals
HIV · Metabolic Syndrome · Osteopenia
Primary: Prevalences of HIV-associated Non-AIDS Conditions (HANA) — 69; 15; 30; 4 Participants — p=0.244
N/A N=1,598 Asymptomatic Bacteriuria Guideline Implementation Study
Infection Due to Indwelling Urinary Catheter · Asymptomatic Bacteriuria
Primary: Number of Cases of ABU That Are Treated Inappropriately With Antibiotics — 1.6; 0.6; 0.5; 0.6 cases/1,000 bed-days
Phase 2 N=29 A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061
HIV-1
Primary: Change From Baseline in Human Immunodeficiency Virus-1 (HIV-1) Viral Load at Day 8 — 4.57; 4.39; 4.41; 4.38 log10 copies/mL
Phase 2 N=52 Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status
Prostate Cancer
Primary: Assess the Efficacy of Radium-223 in Terms of Radiological rPFS — 5.53 months
N/A N=146 The Effect of Pre-discharge Blood Pressure of Patients With Asymptomatic Severe Hypertension in Emergency Department
Hypertension · Emergencies · Asymptomatic Conditions
Primary: Number of Participants Who Died Within 7 Days After Discharge From the Emergency Department — 0; 0 participants
Phase 2 N=21 Study of Acai Juice in Asymptomatic or Minimally Symptomatic Prostate Cancer Patients With Rising PSA
Prostate Cancer
Primary: PSA Response, as Defined by ≥ 50% Decrease in PSA From Baseline — 1 Participants
N/A N=10 Rutgers Pilot for Dental Health Care Worker SARS-CoV-2 Testing
SARS-CoV2 Infection
Primary: Dental Health Care Worker (DHCW) Willingness to Participate in the Study — 10 Participants
N/A N=16 Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study
Alzheimer's Disease Prevention
Primary: Number of Subjects Retained at 6 Months — 11; 4 Participants
N/A N=50 Correlation of Auscultatory Severity of Aortic Stenosis With Trans Thoracic Echocardiography
Aortic Stenosis
Primary: Aortic Stenosis Acceleration Index Compared to Aortic Stenosis Severity — 21; 8; 1; 6 participants
N/A N=125 Microbial Basis of Systemic Malodor and "People Allergic To Me" Conditions
Nutritional and Metabolic Diseases
Primary: Gut Microbiome — 52; 64; 25; 33 Normalized OTU counts
N/A N=98,832 Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor
Erectile Dysfunction · Cardiovascular Diseases · Male Urogenital Diseases
Primary: Percentage of Participants With Underlying Condition Until Day -1 of the Index PDE5i Prescription — 70.23; 55.73 Percentage of participants — p=<0.001
N/A N=1,277,747 COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States
Immunocompromised · Immunosuppressed · Covid-19
Primary: Incidence Rate of Breakthrough Cases of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection — 0.89; 0.34 Events per 100 person-years